We are live on ! Find out more
ACAD icon

Acadia Pharmaceuticals
ACAD

297 hedge funds and large institutions have $7.4B invested in Acadia Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 79 funds opening new positions, 80 increasing their positions, 95 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

204% more first-time investments, than exits

New positions opened: 79 | Existing positions closed: 26

21% more funds holding

Funds holding: 246 → 297 (+51)

14% more capital invested

Capital invested by funds: $6.51B → $7.4B (+$890M)

1.23% less ownership

Funds ownership: 99.26% → 98.03% (-1.2%)

14% less call options, than puts

Call options by funds: $39.2M | Put options by funds: $45.6M

14% less funds holding in top 10

Funds holding in top 10: 7 → 6 (-1)

16% less repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 95

Holders
297
Holders Change
+51
Holders Change %
+20.73%
% of All Funds
6.09%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.12%
New
79
Increased
80
Reduced
95
Closed
26
Calls
$39.2M
Puts
$45.6M
Net Calls
-$6.47M
Net Calls Change
-$6.04M

Top Buyers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$116M
2
JIM
Jupiter Investment Management
United Kingdom
+$43.2M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$41.2M
4
PAMU
Pictet Asset Management (UK)
United Kingdom
+$30M
5
Ameriprise
Ameriprise
Minnesota
+$27.6M

Top Sellers

1
BlackRock
BlackRock
New York
-$114M
2
State Street
State Street
Massachusetts
-$70.8M
3
HM
HealthCor Management
New York
-$57.9M
4
EAM
Eagle Asset Management
Florida
-$46M
5
Northern Trust
Northern Trust
Illinois
-$42.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACA
301
Avoro Capital Advisors
New York
– -$6.13M -145,000 Closed
Manulife (Manufacturers Life Insurance)
302
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$3.04M -72,006 Closed
AL
303
AJO LP
Pennsylvania
– -$2.39M -56,650 Closed
1832 Asset Management
304
1832 Asset Management
Ontario, Canada
– -$2.22M -53,300 Closed
MIM
305
MetLife Investment Management
New Jersey
– -$2.04M -48,173 Closed
UONDDL
306
University of Notre Dame du Lac
Indiana
– -$1.01M -23,824 Closed
KOCAA
307
Knights of Columbus Asset Advisors
Connecticut
– -$724K -17,125 Closed
Simplex Trading
308
Simplex Trading
Illinois
– -$520K -10,834 Closed
AIP
309
Ameritas Investment Partners
Nebraska
– -$414K -9,809 Closed
EMG
310
ETF Managers Group
New Jersey
– -$388K -9,384 Closed
EH
311
Equitable Holdings
New York
– -$368K -8,700 Closed
BC
312
Brinker Capital
Pennsylvania
– -$338K -8,009 Closed
GAM
313
Gotham Asset Management
New York
– -$295K -6,975 Closed
EMG
314
Ellington Management Group
Connecticut
– -$292K -6,900 Closed
NICM
315
Neo Ivy Capital Management
New York
– -$281K -6,661 Closed
FSA
316
Franklin Street Advisors
North Carolina
– -$228K -5,400 Closed
Lazard Asset Management
317
Lazard Asset Management
New York
– -$171K -4,060 Closed
Comerica Bank
318
Comerica Bank
Texas
– -$205K -4,027 Closed
OM
319
Opaleye Management
Massachusetts
– -$63K -1,500 Closed
HNB
320
Huntington National Bank
Ohio
– -$43K -1,025 Closed
QCG
321
Quadrant Capital Group
Ohio
– -$41K -968 Closed
II
322
Inspire Investing
Idaho
– -$8K -191 Closed
FGAM
323
Financial Gravity Asset Management
Texas
– -$98 -2 Closed
9 10 11 12
13

ACAD Hedge Fund Activity: Q2 2020 in Review

297 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Acadia Pharmaceuticals (ACAD) for Q2 2020, worth a combined $7.4B — up 14% from $6.51B a quarter earlier.

Buyers outnumbered sellers: 79 funds opened new ACAD positions and 26 closed out — a net gain of 53 holders — while 80 added to existing stakes and 95 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $116M. The largest seller was BlackRock, cutting an estimated $114M.

  • 297 institutional investors held Acadia Pharmaceuticals (ACAD) as of Q2 2020, up from 246 in Q1 2020.
  • Funds reported $7.4B of Acadia Pharmaceuticals stock for Q2 2020, up 14% quarter-over-quarter.
  • 79 funds opened new Acadia Pharmaceuticals positions in Q2 2020 and 26 closed out, a net change of +53 holders.
  • The largest Acadia Pharmaceuticals buyer in Q2 2020 was Janus Henderson Group, an estimated $116M added.
  • The largest Acadia Pharmaceuticals seller in Q2 2020 was BlackRock, an estimated $114M sold.

Based on aggregated 13F filings for Q2 2020.